Expert Interview
Discussing the recent FDA approval of Medtronic's Affera™ Mapping and Ablation System and Boston Scientific's Farawave Nav for Atrial Fibrillation
Ticker(s): MDT, BSX, ABT, JNJ, PLSEInstitution: University of California, San Diego
- Associate Professor Cardiac Electrophysiology, Division of Cardiology at University of California, San Diego (UCSD).
- Currently manages >500 patients with Atrial Fibrillation.
- Clinical research investigator with advanced training, and his interests include epidemiology and clinical outcomes in patients with all types of cardiac arrhythmias. Dr. Hsu's research has resulted in publications in medical journals such as The New England Journal of Medicine, as well as several top cardiology journals, including Journal of the American College of Cardiology and Circulation.
Please describe your background and practice setting
Added By: ben_adminHow many patients with heart arrhythmia do you manage?
Added By: ben_adminWhat patients do you consider PFA treatment for?
Added By: ben_adminHow are current PFA systems different from one another?
Added By: ben_adminDo you see the usage of PFAs increasing?
Added By: ben_adminWhat are your thoughts on Medtronics Affera and Boston's Farawave Nav systems? Will you have a preference?
Added By: ben_adminAre You Interested In These Questions?
Slingshot Insights Explained
Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.
Reason
*Slingshot Insights provides access to information, not investment advice. We work to support you and facilitate access to experts; however we are not responsible for monitoring calls for the disclosure of MNPI. You should obtain financial, legal and tax advice from your qualified and licensed advisers before deciding to invest in any security.
